Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 7, 2024; 30(13): 1911-1925
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1911
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1911
Figure 4 Apoptotic effect of Liuweiwuling Tablet in hepatitis B virus cell models.
A: Apoptotic effect of Liuweiwuling Tablet (LWWL) in HepG2.2.15 cells; B: Apoptotic evaluation of control group in HepG2.2.15 cells; C: Statistical analysis of apoptosis in HepG2.2.15 cells; D: Apoptotic effect of LWWL in HepG2.A64 cells; E: Apoptotic evaluation of control group in HepG2.A64 cells; F: Statistical analysis of apoptosis in HepG2.A64 cells; G: Apoptotic effect of LWWL in HepG2.1403F cells; H: Apoptotic evaluation of control group in HepG2.1403F cells; I: Statistical analysis of apoptosis in HepG2.1403F cells. aP < 0.05 vs control. LWWL: Liuweiwuling Tablet.
- Citation: Ge FL, Yang Y, Si LL, Li YH, Cao MZ, Wang J, Bai ZF, Ren ZG, Xiao XH, Liu Y. Inhibition of hepatitis B virus via selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet. World J Gastroenterol 2024; 30(13): 1911-1925
- URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1911.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1911